Left ventricular diastolic dysfunction in normotensive diabetic patients in various age strata

Diabetes Research and Clinical Practice

Volumn 79, Issue 1, 2008, Pages 91-96

  Masugata, Hisashi ^a   Senda, Shoichi ^a   Goda, Fuminori ^a   Yoshihara, Yumiko ^b   Yoshikawa, Kay ^b   Fujita, Norihiro ^b   Daikuhara, Hiroyuki ^b   Okuyama, Hiroyuki ^a   Taoka, Teruhisa ^b   Kohno, Masakazu ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b Sakaide Municipal Hospital   (Japan)

Author keywords

Cardiac function; Echocardiography; Type 2 diabetes

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; AGING; BLOOD PRESSURE; DIABETES MELLITUS; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 37549028435     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.08.006     Document Type: Article

References (33)

1. Factor S.M., Borczuk A., Charron M.J., Fein F.S., van Hoeven K.H., and Sonnenblick E.H. Myocardial alterations in diabetes and hypertension. Diabetes Res. Clin. Pract. 31 Suppl. (1996) S133-S142
2. Kempler P. Learning from large cardiovascular clinical trials: classical cardiovascular risk factors. Diabetes Res. Clin. Pract. 68 Suppl. 1 (2005) S43-S47
3. Kannel W.B., Hjortland M., and Castelli W.P. Role of diabetes in congestive heart failure: the Framingham study. Am. J. Cardiol. 34 (1974) 29-34
4. Schernthaner G. Cardiovascular mortality and morbidity in type-2 diabetes mellitus. Diabetes Res. Clin. Pract. 31 Suppl. 1 (1996) S3-S13
5. Vanninen E., Mustonen J., Vainio P., Lansimies E., and Uusitupa M. Left ventricular function and dimensions in newly diagnosed non-insulin-dependent diabetes mellitus. Am. J. Cardiol. 70 (1992) 371-378
6. Beljic T., and Miric M. Improved metabolic control does not reverse left ventricular filling abnormalities in newly diagnosed non-insulin-dependent diabetes patients. Acta Diabetol. 31 (1994) 147-150
7. Gough S.C., Smyllie J., Barker M., Berkin K.E., Rice P.J., and Grant P.J. Diastolic dysfunction is not related to changes in glycaemic control over 6 months in type 2 (non-insulin-dependent) diabetes mellitus: a cross-sectional study. Acta Diabetol. 32 (1995) 110-115
8. Hiramatsu K., Ohara N., Shigematsu S., Aizawa T., Ishihara F., Niwa A., et al. Left ventricular filling abnormalities in non-insulin-dependent diabetes mellitus and improvement by a short-term glycemic control. Am. J. Cardiol. 70 (1992) 1185-1189
9. Gardin J.M., Davidson D.M., Rohan M.K., Butman S., Knoll M., Garcia R., et al. Relationship between age, body size, gender, and blood pressure and Doppler flow measurements in the aorta and pulmonary artery. Am. Heart J. 113 (1987) 101-109
10. Takenaka K., Dabestani A., Gardin J.M., Russell D., Clark S., Allfie A., et al. Left ventricular filling in hypertrophic cardiomyopathy: a pulsed Doppler echocardiography study. J. Am. Coll. Cardiol. 7 (1986) 1263-1271
11. Aeschbacher B.C., Hutter D., Fuhrer J., Weidmann P., Delacretaz E., and Allemann Y. Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am. J. Hypertens. 14 (2001) 106-113
12. Chang N.C., Lai Z.Y., and Wang T.C. Enalapril does not improve left ventricular diastolic dysfunction in young and mild hypertensives without concomitant hypertrophy. Am. J. Hypertens. 9 (1996) 909-914
13. Ahmed S.H., Clark L.L., Pennington W.R., Webb C.S., Bonnema D.D., Leonardi A.H., et al. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 113 (2006) 2089-2096
14. Report of the expert committee on the diagnosis and classification of diabetes mellitus, Diabetes Care 20 (1997) 1183-1197.
15. Devereux R.B., and Wallerson D.C. Reproducibility of echocardiographic left ventricular measurements. Hypertension 9 Suppl. II (1987) II-6-II-18
16. Teichholz L.E., Kreulen T., Herman M.V., and Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am. J. Cardiol. 37 (1976) 7-11
17. Appleton C.P., Firstenberg M.S., Garcia M.J., and Thomas J.D. The echo-Doppler evaluation of left ventricular diastolic function. A current perspective. Cardiol. Clin. 18 (2000) 513-546
18. Poerner T.C., Goebel B., Unglaub P., Sueselbeck T., Strotmann J.M., Pfleger S., et al. Detection of a pseudonormal mitral inflow pattern: an echocardiographic and tissue Doppler study. Echocardiography 20 (2003) 345-356
19. Tei C., Ling L.H., Hodge D.O., Bailey K.R., Oh J.K., Rodeheffer R.J., et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J. Cardiol. 26 (1995) 357-366
20. Tei C., Dujardin K.S., Hodge D.O., Kyle R.A., Tajik A.J., and Seward J.B. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J. Am. Coll. Cardiol. 28 (1996) 658-664
21. Bell D.S. Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease?. Diabetes Care 18 (1995) 708-714
22. Stanley W.C., Lopaschuk G.D., and McCormack J.G. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc. Res. 34 (1997) 25-33
23. Poirier P., Bogaty P., Garneau C., Marois L., and Dumesnil J.G. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 24 (2001) 5-10
24. Zabalgoitia M., Ismaeil M.F., Anderson L., and Maklady F.A. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am. J. Cardiol. 87 (2001) 320-323
25. Boyer J.K., Thanigaraj S., Schechtman K.B., and Perez J.E. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am. J. Cardiol. 93 (2004) 870-875
26. Rodrigues B., Cam M.C., and McNeill J.H. Metabolic disturbances in diabetic cardiomyopathy. Mol. Cell. Biochem. 180 (1998) 53-57
27. Zhou Y.T., Grayburn P., Karim A., Shimabukuro M., Higa M., Baetens D., et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 1784-1789
28. Mizushige K., Yao L., Noma T., Kiyomoto H., Yu Y., Hosomi N., et al. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 101 (2000) 899-907
29. Zile M.R., and Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure. Part II. Causal mechanisms and treatment. Circulation 105 (2002) 1503-1508
30. Villari B., Vassalli G., Schneider J., Chiariello M., and Hess O.M. Age dependency of left ventricular diastolic function in pressure overload hypertrophy. J. Am. Coll. Cardiol. 29 (1997) 181-186
31. Burlew B.S. Diastolic dysfunction in the elderly-the interstitial issue. Am. J. Geriatr. Cardiol. 13 (2004) 29-38
32. Japanese Society of Hypertension, Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004), Hypertens. Res. 29 (Suppl.) (2006) S1-S105.
33. Schillaci G., Pasqualini L., Verdecchia P., Vaudo G., Marchesi S., Porcellati C., et al. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J. Am. Coll. Cardiol. 39 (2002) 2005-2011